The EPS projection of Castlight Health, inc. (NYSE:CSLT) for quarter ended 2016-09-30 is $-0.15. Last week, the projection for EPS was $-0.15 against target of $-0.15, a month earlier. While 2-months ago, this projection was $-0.15 versus forecast of $-0.15a quarter months earlier, posting a deviation of 0%.
Castlight Health, inc. (NYSE:CSLT) posted that 18 days earlier, the share price was revised 3 times on upside. In addition, negative revisions were 0.
In last week, negative EPS revisions were 0 times and positive EPS revisions were 0 times. In last one-month and two month the positive revisions were 0 and 1. While in last 120 and 90 days, positive revisions were 3, and 3, correspondingly.
The per-share earnings downgrade for Castlight Health, inc. (NYSE:CSLT) in the preceding 30 and 120 were 1 and 0. While in 60 and 90 days were 0, and 0, in that order.
Castlight Health, inc. (NYSE:CSLT) EPS target was $-0.15 for the quarter closed 1. It was based on 5 calls. As on 2016-05-10 the EPS was $-0.19. The change was $0.02, posting a deviation of 9.52%. The price projections gave a standard deviation of 0.01.
Quarterly Sales Estimates
Castlight Health, inc. (NYSE:CSLT) sales prediction for the fiscal 2016 stands at $28.664 and the median estimate is at $28.828. Almost 6 analysts gave sales target.
Among this, the highest sales estimate is $29.11 while the lowest target is $27.82 showing standard deviation of 0.507%.
As many as 6 analysts have positive sales targets revision while 6 reduced sales estimates, posting a deviation of 0%.
Last month, 6 experts have positive sales number revision. Also, 6 research groups lowered the sales projections, posting a deviation of 0%.
A quarter ago, 6 hiked sales target and 6 reduced sales forecast, posting a deviation of -0.361%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...